Page last updated: 2024-08-16

sb 202190 and bi 2536

sb 202190 has been researched along with bi 2536 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Brasier, AR; Chen, H; Liu, Z; Tian, B; Wang, P; Wold, EA; Zhou, J1
Munoz, L1

Reviews

2 review(s) available for sb 202190 and bi 2536

ArticleYear
Drug Discovery Targeting Bromodomain-Containing Protein 4.
    Journal of medicinal chemistry, 2017, 06-08, Volume: 60, Issue:11

    Topics: Cell Cycle Proteins; Drug Discovery; Humans; Nuclear Proteins; Transcription Factors

2017
Non-kinase targets of protein kinase inhibitors.
    Nature reviews. Drug discovery, 2017, Volume: 16, Issue:6

    Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases

2017

Other Studies

1 other study(ies) available for sb 202190 and bi 2536

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
chemdatabank.com